FYN overexpression partially protected Fgf18-CKO mice from hypertrophy (Fig. 7b), as well as cardiac function (Fig. 7c, Supplementary Table 9), myocardial fibrosis (Fig. 7d), and hydroxyproline content (Fig. 7e). The gene discussed is FGF18; the disease is Myocardial fibrosis.